Verano Holdings (VRNO) Return on Capital Employed (2022 - 2026)
Verano Holdings (VRNO) posted quarterly Return on Capital Employed of 6.79% for Q1 2026, up 671.0% year-over-year from 0.88% in Q1 2025, and down 7.3% quarter-over-quarter from 6.32% in Q4 2025.
Verano Holdings (VRNO) Return on Capital Employed (2022 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Return on Capital Employed for 5 consecutive years, with 6.79% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed rose 671.0% year-over-year to 6.79%; the TTM figure through Mar 2026 stood at 6.79% (up 671.0% YoY), while the FY2025 annual figure was 6.2%, up 594.0% from the prior year.
- Return on Capital Employed retreated to 6.79% in Q1 2026 per VRNO's latest filing, from 6.32% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 4.41% in Q4 2023 and bottomed at 14.16% in Q3 2025.
- Historically, Return on Capital Employed has averaged 4.96% across 5 years, with a median of 6.32% in 2025.
- Annual changes were most pronounced in 2023 — Return on Capital Employed jumped 1244 bps — and 2025, when it tumbled 1737 bps.
- Verano Holdings' Return on Capital Employed stood at 8.03% in 2022, then soared by 155 bps to 4.41% in 2023, then plunged by 376 bps to 12.15% in 2024, then jumped by 48 bps to 6.32% in 2025, then dropped by 7 bps to 6.79% in 2026.
- Business Quant data shows VRNO's Return on Capital Employed at 6.79% in Q1 2026, 6.32% in Q4 2025, and 14.16% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Verano Holdings | 433.71 Mn | 348.51 Mn | 99.70 Mn | -8.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.28% |
| Mar 31, 2026 | -6.79% |
| Dec 31, 2025 | -6.32% |
| Sep 30, 2025 | -14.16% |
| Jun 30, 2025 | -13.60% |
| Mar 31, 2025 | -13.50% |
| Dec 31, 2024 | -12.15% |
| Sep 30, 2024 | 2.55% |
| Jun 30, 2024 | 3.68% |
| Mar 31, 2024 | 3.87% |
| Dec 31, 2023 | 4.41% |
| Sep 30, 2023 | -5.13% |
| Jun 30, 2023 | -5.26% |
| Mar 31, 2023 | -6.86% |
| Dec 31, 2022 | -8.03% |
| Sep 30, 2022 | 2.95% |